Cottreau J, Tucker A, Crutchley R, Garey KW. Crofelemer for the treatment of secretory diarrhea. Expert Rev Gastroenterol Hepatol. 2012 Jan;6(1):17-23.

Crutchley RD, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk Factors for Vitamin D Deficiency in HIV-Infected Patients in the South Central United States. AIDS Res Hum Retroviruses. 2011 Oct 19. [Epub ahead of print]

Crutchley RD, Ma Q, Sulaiman A, Hochreitter J, Morse GD. Within-patient atazanavir trough concentration monitoring in HIV-1-infected patients. J Pharm Pract. 2011 Apr;24(2):216-22.

Crutchley RD, Miller J, Garey KW. Crofelemer, a novel agent for treatment of secretory diarrhea. Ann Pharmacother. 2010 May;44(5):878-84.

Naser L. Rezk, Rustin D. Crutchley and Angela D.M. Kashuba. Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring. Therapeutic Drug Monitoring. 2006; 28(4): 517-25.

Naser L. Rezk, Rustin D. Crutchley and Angela D.M. Kashuba. Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. Journal of Chromatography B. 2005; 822(1-2): 201-208.